<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We describe 4 patients with <z:hpo ids='HP_0003256'>coagulopathy</z:hpo> and <z:hpo ids='HP_0002633'>vasculitis</z:hpo> that demonstrated marked tissue <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and <z:mp ids='MP_0001651'>necrosis</z:mp> </plain></SENT>
<SENT sid="1" pm="."><plain>In the clinical setting of rapid evolution of vascular insufficiency, the possibility of combined vasculopathic processes should be considered </plain></SENT>
<SENT sid="2" pm="."><plain>This is especially so in patients with underlying <z:e sem="disease" ids="C0009782" disease_type="Disease or Syndrome" abbrv="">connective tissue disease</z:e> such as <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> or <z:hpo ids='HP_0001370'>rheumatoid arthritis</z:hpo>, in which both <z:hpo ids='HP_0002633'>vasculitis</z:hpo> and <z:hpo ids='HP_0003613'>antiphospholipid antibodies</z:hpo> are frequently present </plain></SENT>
<SENT sid="3" pm="."><plain>Treatment of both pathologic processes may be required to prevent progressive tissue <z:e sem="disease" ids="C0022116" disease_type="Disease or Syndrome" abbrv="">ischemia</z:e> and <z:mp ids='MP_0001651'>necrosis</z:mp> </plain></SENT>
<SENT sid="4" pm="."><plain>The use of antiplatelet and/or anticoagulation should be given consideration in addition to <z:chebi fb="1" ids="35705">immunosuppressive agents</z:chebi> </plain></SENT>
</text></document>